Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gebski

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Australian Dental Journal|December 3, 2003
Tongue cancer: do patients younger than 40 do worse?D M Hyam, R C Conway, Y Sathiyaseelan, et al.
The Medical Journal of Australia|May 2, 1988
Management of oesophageal cancer at Westmead Hospital from 1979-1985I C O'Rourke, D C Johnson, K W Tiver, et al.
Radiation Research|March 13, 1998
A test of lymphoma induction by long-term exposure of E mu-Pim1 transgenic mice to 50 Hz magnetic fieldsA W Harris, A Basten, V Gebski, et al.
The Medical Journal of Australia|February 4, 1991
Long-term survival after radical treatment for cancer of the oesophagusI C O'Rourke, D C Johnson, K W Tiver, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2013
High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphyF Noushi, A J Spillane, R F Uren, et al.
Pathology|August 29, 2001
Effect of global system for mobile communication (gsm)-like radiofrequency fields on vascular permeability in mouse brainJ W Finnie, P C Blumbergs, J Manavis, et al.
British Journal of Cancer|January 14, 2010
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trialN C Tebbutt, M M Cummins, T Sourjina, et al.
Breast Cancer Research and Treatment|March 30, 2011
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancerC K Lee, M Hudson, M Stockler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2009
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancerM D Green, P A Francis, V Gebski, et al.
The New England Journal of Medicine|December 10, 1987
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategiesA Coates, V Gebski, J F Bishop, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Australian Dental Journal|December 3, 2003
Tongue cancer: do patients younger than 40 do worse?D M Hyam, R C Conway, Y Sathiyaseelan, et al.
The Medical Journal of Australia|May 2, 1988
Management of oesophageal cancer at Westmead Hospital from 1979-1985I C O'Rourke, D C Johnson, K W Tiver, et al.
Radiation Research|March 13, 1998
A test of lymphoma induction by long-term exposure of E mu-Pim1 transgenic mice to 50 Hz magnetic fieldsA W Harris, A Basten, V Gebski, et al.
The Medical Journal of Australia|February 4, 1991
Long-term survival after radical treatment for cancer of the oesophagusI C O'Rourke, D C Johnson, K W Tiver, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 23, 2013
High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphyF Noushi, A J Spillane, R F Uren, et al.
Pathology|August 29, 2001
Effect of global system for mobile communication (gsm)-like radiofrequency fields on vascular permeability in mouse brainJ W Finnie, P C Blumbergs, J Manavis, et al.
British Journal of Cancer|January 14, 2010
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trialN C Tebbutt, M M Cummins, T Sourjina, et al.
Breast Cancer Research and Treatment|March 30, 2011
A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancerC K Lee, M Hudson, M Stockler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2009
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancerM D Green, P A Francis, V Gebski, et al.
The New England Journal of Medicine|December 10, 1987
Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategiesA Coates, V Gebski, J F Bishop, et al.
Pageof 11